What We Do
World-leading Science and Innovation
Internationally recognized for groundbreaking science and innovation, MAP scientists have changed the way the world understands the health consequences of social inequality in cities.
Demonstrating the promise and value of the ‘Housing First’ model in Canada
MAP led the Toronto arm of the largest randomized controlled trial in history to evaluate solutions to end chronic homelessness.
The national, ‘At Home/Chez Soi’ project involved more than 2,000 people who were homeless and living with mental illness in cities across the country.
In 2015, results from the study helped to influence the province to set a goal to end chronic homelessness in Ontario within the next 10 years.
Street-level, Scalable Solutions
We design and test real-world solutions to complex, urban health problems — many at the intersection of health and inequality. MAP scientists work quickly to meet urgent needs in real time, focused on concrete results and long-term sustainability.
What if everyone could afford the medication they need?
Research shows that 2.4 million people in Canada don’t take the drugs they need because they can’t afford them.
This large study is the first in Canada to test the effects of giving people access to essential medicines for free, and to measure the impact of medication costs on health outcomes.
Initial results are very promising, and are already informing the universal pharmacare debate in Canada.
Authentic, long-term community and policy partnerships are at the heart of what we do. Together, we are charting the way to the world’s healthiest cities: places where everyone can thrive.
Helping people who inject drugs build resilience in their communities amidst ongoing grief and loss of people close to them.
Many people who inject drugs, and people who work in harm reduction services, are living with grief and loss stemming from the ongoing crisis of opioid-overdose related deaths. These experiences of loss can take a psychological toll, yet there are few bereavement services available for people with theses experiences.
Working with our community partners, including people who inject drugs and harm reduction workers, we will use results from this research to develop an intervention to help people who inject drugs to develop coping strategies and build resilient communities.